Journal of Aging Research and Lifestyle,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 1, 2024
Because
nutrition
is
one
of
the
main
factors
related
to
Alzheimer's
disease
(AD),
questions
arise
about
how
taking
nutrients
as
supplements
can
affect
its
pathophysiological
process.In
present
study,
an
overview
potential
effects
nutritional
supplementation
on
biomarkers
AD
pathophysiology
(i.e.,
amyloid-β
and
tau)
explored.Trials
testing
single
or
combined
versus
placebo
identified
some
biomarkers,
but
changes
were
not
always
accompanied
by
positive
cognitive
function.Differences
in
characteristics
studied
populations
(cognitive
status,
age,
educational
level),
choice
nutrient
combinations
doses,
duration
intervention,
adjustments
for
confounders
are
that
may
explain
discrepancies
findings.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(3), P. 1333 - 1333
Published: Feb. 4, 2025
Neurodegenerative
diseases
such
as
Alzheimer’s
disease
(AD),
Parkinson’s
(PD),
amyotrophic
lateral
sclerosis
(ALS),
and
multiple
(MS),
which
are
a
consequence
of
the
progressive
loss
neuronal
function
structure,
cause
significant
cognitive
impairment.
The
incidence
these
in
world’s
population
is
constantly
increasing
result
an
aging
population.
Although
genetic
environmental
factors
most
often
mentioned
pathogenetic
diseases,
evidence
points
to
important
role
proper
nutrition
prevention
support
treatment
disorders.
A
healthy,
balanced
diet
can
mitigate
risks
associated
with
risk
above
slow
progression
by
reducing
oxidative
stress
inflammation.
Vitamins
B,
D,
E,
C,
K,
have
been
shown
functions
protect
nervous
system.
This
review
demonstrates
importance
vitamins
preventing
supporting
therapy
neurodegenerative
diseases.
Information
regarding
health-promoting
properties
must
be
effectively
communicated
consumers
seeking
their
health,
particularly
context
Consequently,
this
also
examines
authorized
health
claims
under
EU
food
law
related
vitamins,
assessing
promoting
awareness
vitamins’
potential
benefits
for
neuroprotection
management
Psychogeriatrics,
Journal Year:
2025,
Volume and Issue:
25(2)
Published: Feb. 27, 2025
Abstract
Background
Dementia
is
a
global
health
concern
which
can
be
mitigated
by
primary
prevention
and
improved
literacy.
Effective
educational
initiatives
are
informed
studies
of
dementia
knowledge.
However,
most
these
conducted
in
high‐income
countries,
leaving
the
Balkan
region
underrepresented.
This
study
aimed
to
conduct
first
investigation
knowledge
among
Bulgarian
population,
exploring
recognition
symptoms,
general
knowledge,
risk
factors
awareness.
Methods
Using
an
online
survey
we
assessed
following
components
knowledge:
(i)
symptoms
from
vignette;
(ii)
literacy
measured
with
Knowledge
Assessment
Scale
(DKAS);
(iii)
about
factors.
Demographic
characteristics,
previous
experience
dementia,
patterns
informing
were
also
considered
study.
Results
One
thousand,
eight
hundred
ninety‐six
adults
(mean
age
=
44.99;
51.79%
female)
completed
survey.
Half
respondents
correctly
recognised
vignette.
The
average
DKAS
score
was
9.51.
linked
education,
marital
status,
employment,
ethnicity,
informational
sources.
56.7%
thought
normal
part
ageing
74.8%
did
not
know
healthy
lifestyle
reduces
dementia.
number
identified
(out
17),
many
mistakenly
citing
dental
fillings,
laziness,
witchcraft
as
contributors
Conclusions
society
has
poor
understanding
highlighting
need
for
awareness
education.
Policy‐makers
should
prioritise
social
issue
take
coordinated
actions
educate
eradicate
harmful
misconceptions.
American Journal of Health Behavior,
Journal Year:
2025,
Volume and Issue:
49(1), P. 14 - 22
Published: Jan. 31, 2025
Background:
Patients
suffering
from
Alzheimer's
disease
usually
experience
different
neuroanatomical
changes
such
as
depression,
apathy
and
irritability.
Other
cognitive
behaviours
found
are
linked
with
impairment
well
disease.
Cardiovascular
issues
also
to
be
common
among
the
patients,
Aim
of
Study:
This
study
aims
assess
health
behavior
their
association
within
progression
impairment.
For
this
purpose,
hyperintensities
in
white
matter
(WHM)
were
observed.
Methodology:
In
current
longitudinal
study,
grey
atrophy
WMH
changes,
is
observed
cohort.
regard,
120
participants
included
while
310
220
control
groups
incorporated.
Neuroanatomical
determined
by
using
Neuropsychiatric
Inventory,
which
classified
into
apathy,
affective
hyperactivity
subsyndromes.
Automatic
technique
was
used
for
measuring
WMH.
Results:
The
results
obtained
linear
mixed-effects
models
show
that
has
a
significant
other
subsyndromes
groups.
Significant
context
vascular
risks.
Conclusion:
identified
major
contributor
NPS
moderate
Current Issues in Molecular Biology,
Journal Year:
2025,
Volume and Issue:
47(5), P. 318 - 318
Published: April 29, 2025
Alzheimer’s
disease
(AD)
is
a
complex
neurodegenerative
disorder
characterized
by
progressive
cognitive
decline,
memory
impairment,
and
synaptic
dysfunction
[...]
Journal of Applied Gerontology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 29, 2025
Symptoms
of
dementia
can
impact
the
nutritional
status
and
quality
life
people
with
dementia,
but
there
is
limited
research
exploring
dietitian’s
role
in
post-diagnostic
care.
This
study
aims
to
explore
a
dietitian
multidisciplinary
program
for
living
community.
Participants
twelve-week
multicomponent,
intervention
care
partners
were
offered
three
consultations
receive
dietary
assessment,
education
advice.
Key
clinical
findings
from
dietetics
case
notes
40
analyzed
using
composite
series
approach.
Of
these,
39
required
ongoing
nutrition
support
intervention.
Common
issues
identified
include
insufficient
energy
and/or
nutrient
intake,
unintentional
weight
loss,
poor
management
comorbidities
difficulties
coordination
Dietitians
are
an
integral
part
multicomponent
dementia.
Future
work
needed
optimize
dietetic
models.
Running
headline.
Dietetics
early
Journal of Alzheimer s Disease,
Journal Year:
2024,
Volume and Issue:
99(4), P. 1173 - 1186
Published: May 17, 2024
Background:
Early
intervention
is
essential
for
meaningful
disease
modification
in
Alzheimer’s
(AD).
Objective:
We
aimed
to
determine
the
efficacy
and
safety
of
pharmacologic
nutritional
interventions
early
AD.
Methods:
PubMed,
Embase,
Cochrane
Library,
ClinicalTrials.gov
were
searched
from
database
inception
until
1
September
2023.
included
randomized
controlled
trials
that
evaluated
Only
demonstrated
compared
placebo
network
meta-analysis
(NMA).
Then
we
performed
frequentist
fixed-effects
NMA
rank
interventions.
GRADE
criteria
used
evaluate
level
evidence.
Results:
Fifty-eight
including
a
total
33,864
participants
48
eligible
inclusion.
Among
analyzed,
only
6
(12.5%)
treatments—
ranging
low
high
certainty—
showed
significant
improvement
cognitive
decline
placebo.
High
certainty
evidence
indicated
donanemab
(standardized
mean
difference
[SMD]
–0.239,
95%
confidence
interval
[CI]
–0.343
–0.134)
lecanemab
(SMD
–0.194,
CI
–0.279
–0.108)
moderately
slowed
clinical
progression
patients
with
amyloid
pathology.
Additionally,
methylphenidate,
donepezil,
LipiDiDiet,
aducanumab
However,
there
was
no
serious
adverse
events
as
reported
between
six
Conclusions:
12.5%
studied
reducing
impairment
Donanemab
have
potential
slow
Further
required
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(16), P. 8982 - 8982
Published: Aug. 18, 2024
Alzheimer's
disease
(AD)
is
characterized
by,
among
other
things,
dementia
and
a
decline
in
cognitive
performance.
In
AD,
has
neurodegenerative
features
starts
with
mild
impairment
(MCI).
Research
indicates
that
apoptosis
neuronal
loss
occur
which
oxidative
stress
plays
an
important
role.
Therefore,
reducing
antioxidants
natural
strategy
to
prevent
slow
down
the
progression
of
AD.
Carotenoids
are
pigments
commonly
found
fruits
vegetables.
They
include
lipophilic
carotenes,
such
as
lycopene,
α-
β-carotenes,
more
polar
xanthophylls,
for
example,
lutein,
zeaxanthin,
canthaxanthin,
β-cryptoxanthin.
can
cross
blood-brain
barrier
(BBB)
scavenge
free
radicals,
especially
singlet
oxygen,
helps
peroxidation
lipids
abundant
brain.
As
result,
carotenoids
have
neuroprotective
potential.
Numerous
vivo
vitro
studies,
well
randomized
controlled
trials,
mostly
confirmed
help
neurodegeneration
alleviate
While
not
been
officially
approved
AD
therapy,
they
indicated
diet
recommended
including
consumption
products
rich
carotenoids.
This
review
summarizes
latest
research
findings
supporting
potential
use
preventing
alleviating
symptoms.
A
literature
suggests
should
be
promoted
avoid
One
goals
food
industry
encourage
enrichment
functional
substances,
carotenoids,
may
reduce
risk
diseases.
European Journal of Nutrition,
Journal Year:
2023,
Volume and Issue:
62(S1), P. 1 - 16
Published: Nov. 28, 2023
Populations
in
crisis!A
global
overview
of
health
challenges
and
policy
efforts
within
the
scope
current
nutrition
issues,
from
persistent
forms
undernutrition,
including
micronutrient
deficiency,
to
diet-related
chronic
diseases.
Nutrition
science
has
evolved
a
therapeutic
prevention
emphasis
include
focus
on
diets
food
systems.
Working
consensus
definitions
are
needed,
as
well
guidance
related
healthy
emerging
issues
that
require
further
research
building.
Between
nutrient
deficiency
disease,
focusing
exclusively
extremes
overt
disease
prevention,
equipping
bodies
with
ability
cope
physiologic,
metabolic,
psychological
stress.
Just
what
is
'optimal
nutrition',
valid
public
goal,
terminology
being
provided
by
community?
'healthspan',
resilience,
intrinsic
capacity
may
provide
evidence
support
optimal
nutrition.
Finally,
experts
views
ongoing
achieving
or
acceptance
various
interventions
for
promotion,
how
these
can
inform
government
policies.Nutrition
topics
receive
particular
proceedings
choline,
NAD-replenishment
neurodegenerative
diseases,
xanthophyll
carotenoids.
Choline
crucial
essential
cellular
metabolism,
requiring
consumption
foods
supplements
due
inadequate
endogenous
synthesis.
Maternal
choline
intake
vital
fetal
infant
development
prevent
neural
tube
defects.
Neurodegenerative
diseases
pose
growing
challenge,
lacking
effective
therapies.
Nutrition,
NAD-replenishing
nutrients,
might
aid
prevention.
Emerging
indicates
carotenoids
enhance
vision
cognition,
potentially
impacting
age-related
Brain Sciences,
Journal Year:
2023,
Volume and Issue:
14(1), P. 41 - 41
Published: Dec. 31, 2023
One
of
the
major
obstacles
confronting
formulation
a
mechanistic
understanding
for
Alzheimer’s
disease
(AD)
is
its
immense
complexity—a
complexity
that
traverses
full
structural
and
phenomenological
spectrum,
including
molecular,
macromolecular,
cellular,
neurological
behavioural
processes.
This
reflected
by
equally
complex
diversity
risk
factors
associated
with
AD.
However,
more
than
merely
mirroring
complexity,
also
provide
fundamental
insights
into
aetiology
pathogenesis
AD
as
neurodegenerative
disorder
since
they
are
central
to
initiation
subsequent
propagation.
Based
on
systematic
literature
assessment,
this
review
identified
30
then
extended
analysis
further
identify
neuroinflammation
unifying
mechanism
present
in
all
factors.
Although
other
mechanisms
(e.g.,
vasculopathy,
proteopathy)
were
multiple
factors,
dysfunction
neuroimmune–neuroinflammation
axis
was
uniquely
Though
nature
neuroinflammatory
involvement
varied,
activation
microglia
release
pro-inflammatory
cytokines
common
pathway
shared
observation
provides
evidence
importance
immunopathic
aetiopathogenesis
Clinical Cosmetic and Investigational Dermatology,
Journal Year:
2024,
Volume and Issue:
Volume 17, P. 399 - 407
Published: Feb. 1, 2024
Abstract:
We
present
the
case
of
a
58-year-old
male
patient
who
presented
with
pruritic
skin
plaques
and
papules
on
scalp,
face,
back,
back
hands
for
over
year.
The
symptoms
worsened
upon
exposure
to
sunlight
improved
cloudy
days.
Despite
previous
attempts
at
treatment
glucocorticoid
ointment
antihistamine
drugs,
experienced
progressive
aggravation
symptoms.
Physical
examination
revealed
hypertrophic
infiltrating
nodules,
significant
scratches
local
exudation.
Skin
biopsy
confirmed
diagnosis
sun-induced
dermatosis.
was
initiated
tofacitinib,
an
oral
Janus
Kinase
inhibitor,
along
halometasone
ointment,
ebastine
tablets,
strict
sun
protection.
Over
course
four
revisits
spanning
months,
improvement
in
symptoms,
rash
almost
disappearing
pruritus
subsiding.
well
tolerated
no
adverse
effects
were
observed.
Follow-up
six
months
post-treatment
showed
recurrence
This
highlights
efficacy
tofacitinib
managing
suggests
it
as
potential
therapeutic
option
similar
cases.
Keywords:
dermatosis,
chronic
actinic
dermatitis,